SCHEMBL12848352

SCHEMBL12848352

C=CC(=O)OC1CC2CCC21C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.39
ELANE P08246 2/20 0.38
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
XBP1 P17861 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
ATP1A1 P05023 1/20 0.32
ATP1B1 P05026 1/20 0.32
ATP1A3 P13637 1/20 0.32
ATP1B2 P14415 1/20 0.32
ATP1A2 P50993 1/20 0.32
ATP1B3 P54709 1/20 0.32
FXYD2 P54710 1/20 0.32
ATP1A4 Q13733 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30188344 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL1185726 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL9227026 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL17917072 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL15778738 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL26704 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL16168302 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL22902902 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL21838264 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A
SCHEMBL29516950 0.81 CYP2C19 (0.59) CYP2C19ELANEMAPTMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9507263-B2 Underlay film composition for imprints and method of forming pattern and pattern formation method using the same FUJIFILM CORPORATION (JP) 2016-11-29 US disclosed
US-8859071-B2 Curable composition for imprint, patterning method and pattern FUJIFILM CORPORATION (JP) 2014-10-14 US disclosed
US-20140220353-A1 UNDERLAY FILM COMPOSITION FOR IMPRINTS AND METHOD OF FORMING PATTERN AND PATTERN FORMATION METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2014-08-07 US disclosed
US-20140154471-A1 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2014-06-05 US disclosed
WO-2013008940-A1 CURABLE COMPOSITION FOR IMPRINTS, PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2013-01-17 WO disclosed
US-20110059302-A1 CURABLE COMPOSITION FOR IMPRINT, PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2011-03-10 US disclosed
WO-2010104188-A1 CURABLE COMPOSITION FOR IMPRINT,PATTERNING METHOD AND PATTERN FUJIFILM CORPORATION (JP) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059302-A1 CURABLE COMPOSITION FOR IMPRINT, PATTERNING METHOD AND PATTERN DNMT3L, DNMT3A, DNMT1 CYP2C19 3009/4885ELANE 2804/4885MAPT 1381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.